CLPT Q1 2026 Earnings EPS Misses Estimates as ClearPoint Neuro Continues Strategic Investments NJR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Regulatory Execution FBRX Q1 2026 Earnings PreRevenue Biotech Reports Narrow EPS Miss Amid Ongoing Development GFS Q1 2026 Earnings EPS Surges Past Estimates Amid Sharp Stock Decline DMAC Q1 2026 Earnings Wider Loss Than Expected as Clinical Pipeline Advances IRIX Q1 2026 Earnings NarrowerThanExpected Loss Marks Positive Surprise